114934-97-3

Upstream product

• 114978-02-8 2,5-di-O-benzyl-1,3(R):4,6(R)-di-O-benzylidene-D-mannitol 
• 100-39-0 benzyl bromide 
• 61490-28-6 1,3:4,6-di-O-benzylidene-D-mannitol 
• 17618-04-1 2,5-di-O-benzyl-D-mannitol 
• 98-88-4 benzoyl chloride 

Downstream Products

• 145484-36-2 <2-O-benzyl-3-O-(p-methoxybenzyl)-sn-glycero(1)>benzyloxo(diisopropylamido)phosphorus 
• 145454-65-5 1-O-benzoyl-2-O-benzyl-3-O-(p-methoxybenzyl)-sn-glycerol 
• 145454-62-2 (R)-2-(benzyloxy)-3-[(4-methoxybenzyl)oxy]propan-1-ol 
• 109430-97-9 (-)-2-(benzyloxy)-3-hydroxypropyl benzoate 
• 145484-35-1 Benzoic acid (R)-2-benzyloxy-3-oxo-propyl ester 
• 114935-10-3 C₁₇H₁₇⁽²⁾HO₄ 
• 114935-11-4 C₁₇H₁₇⁽²⁾HO₄ 

Relevant academic research and scientific papers

D-mannitol derivatives as HIV aspartyl protease inhibitors

A D-mannitol derivative selected from the group consisting of a compound of formula pharmaceutically acceptable derivatives thereof and where applicable or appropriate pharmaceutically acceptable salts thereof, wherein R1, R2, R3and R4are the same or different and may each independently be selected from among alkyl and aryl (i.e. aromatic including aromatic like) groups. The D-mannitol derivatives may be used as HIV aspartyl protease inhibitors.